Cargando…
Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma
Nuclear factor κB (NFκB) activation plays a crucial role in anti-apoptotic responses in response to the apoptotic signaling during tumor necrosis factor (TNFα) stimulation in Multiple Myeloma (MM). Although several drugs have been found effective for the treatment of MM by mainly inhibiting NFκB pat...
Autores principales: | Peng, Huiming, Wen, Jianguo, Li, Hongwei, Chang, Jeff, Zhou, Xiaobo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051063/ https://www.ncbi.nlm.nih.gov/pubmed/21408099 http://dx.doi.org/10.1371/journal.pone.0014750 |
Ejemplares similares
-
The NF-κB Activating Pathways in Multiple Myeloma
por: Roy, Payel, et al.
Publicado: (2018) -
Targeting NF-κB Signaling for Multiple Myeloma
por: Wong, Ada Hang-Heng, et al.
Publicado: (2020) -
Inhibition of VCP modulates NF-κB signaling pathway to suppress multiple myeloma cell proliferation and osteoclast differentiation
por: Wei, Rongfang, et al.
Publicado: (2023) -
Targeting the Non-Canonical NF-κB Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Burley, Thomas A., et al.
Publicado: (2022) -
Betulinic Acid Induces ROS-Dependent Apoptosis and S-Phase Arrest by Inhibiting the NF-κB Pathway in Human Multiple Myeloma
por: Shen, Min, et al.
Publicado: (2019)